The psychometric validity of the Montgomery-Asberg Depression Rating Scale (MADRS) in recent onset schizophrenia spectrum disorders
Sarah E Herniman, Sue M Cotton, Kelly A Allott, Lisa J Phillips, Stephen J Wood
SCHIZOPHRENIA RESEARCH | ELSEVIER | Published : 2021
Earlier recognition and accurate assessment of depressive symptoms is important to improving outcomes in individuals with recent-onset schizophrenia spectrum disorders (termed SSD hereafter)-regardless of whether positive psychotic symptoms are present or have resolved. The Montgomery-Åsberg Depression Rating Scale (MADRS) is frequently used to assess depressive symptoms in SSD, but no study has examined the psychometric validity of MADRS scores in individuals exclusively with SSD and sub-grouped by those with and without positive psychotic symptoms. This study involved baseline data from the Psychosis Recent Onset GRoningen Survey (PROGR-S). Measures used were: MADRS, depressive and negativ..View full abstract
Awarded by National Health and Medical Research Council Senior Research Fellowship
Awarded by Career Development Fellowship from the NHMRC
SEH is supported by a Research Training Program Scholarship awarded by the Australian Commonwealth Government. SMC is supported by a National Health and Medical Research Council Senior Research Fellowship (APP1136344). KA is supported by a Career Development Fellowship from the NHMRC (1141207). The framework of the PROGR-S-cohort is supported by the University Centre of Psychiatry of the University Medical Centre Groningen, Lentis Mental Health Institute, Groningen, and the Rob Giel Research Centre, Groningen, The Netherlands.